Recognizing ADHD in Adults with Comorbid Mood Disorders: Implications for Identification and Management

References

• . Still GF. Some abnormal psychical conditions in children: the Goulstonian lectures. Lancet. 1902;1:1008–1012
   Google Scholar
• . Wood DR, Reimherr FW, Wender PH, Johnson GE. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry. 1976;33(12):1453–1460
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994
   Google Scholar
• . Bloom B, Cohen RA. Summary health statistics for U.S. children: National Health Interview Survey, 2006. Vital Health Stat 10. 2007;(234):1–79
   Google Scholar
• . Visser SN, Lesesne CA, Perou R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics. 2007;119( suppl 1):S99–S106
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2(2):104–113
   PubMedGoogle Scholar
• . Weiss M, Hechtman LT, Weiss G. ADHD in Adulthood: A Guide to Current Theory, Diagnosis, and Treatment. Baltimore, MD: Johns Hopkins University Press; 1999
   Google Scholar
• . Kessler RC, Adler LA, Barkley R, . Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57(11):1442–1451
   PubMed Web of Science ®Google Scholar
• . Barkley RA, Murphy KR, Fischer M. ADHD in Adults: What the Science Says. New York, NY: Guilford Press; 2008
   Google Scholar
• . Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36( suppl 10):85S–121S
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–165
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Biederman J, Spencer T, . Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000;48(1):9–20
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Perlis RH, Doyle AE, . Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–1323
   PubMed Web of Science ®Google Scholar
• . Shaw P, Eckstrand K, Sharp W, . Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA. 2007;104(49):19649–19654
   PubMed Web of Science ®Google Scholar
• . Faraone SV. Etiology and pathophysiology of adult attention-deficit/hyperactivity disorder. Prim Psychiatry. 2004;11:28–40
   Google Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187–201
   PubMed Web of Science ®Google Scholar
• . Goodman DW. The consequences of attention-deficit/hyperactivity disorder in adults. J Psychiatr Pract. 2007;13(5):318–327
   PubMedGoogle Scholar
• . Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiatry. 2004;65( suppl 3):27–37
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Fayyad J, De Graaf R, Kessler R, . Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190:402–409
   PubMed Web of Science ®Google Scholar
• . Nierenberg AA, Miyahara S, Spencer T, ; STEP-BD Investigators. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005; 57(11):1467–1473
   PubMed Web of Science ®Google Scholar
• . Alpert JE, Maddocks A, Nierenberg AA, . Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 1996;62(3):213–219
   PubMed Web of Science ®Google Scholar
• . Schubiner H, Tzelepsis A, Milberger S, . Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000;61(4):244–251
   PubMed Web of Science ®Google Scholar
• . Van Ameringen M, Mancini C, Patterson B, Simpson W, Freeman W. Adult attention-deficit/hyperactivity disorder: prevalence in an anxiety disorders clinic population. Paper presented at: the 2008 Annual Conference of the Anxiety Disorders Association 28th Annual Meeting; March 2008; Savannah, GA
   Google Scholar
• . de Graaf R, Kessler RC, Fayyad J, . The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008;65(12):835–842
   PubMed Web of Science ®Google Scholar
• . Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord. 2007;10(4):335–342
   PubMedGoogle Scholar
• . Murphy KR, Barkley RA, Bush T. Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history. J Nerv Ment Dis. 2002;190(3):147–157
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524–540
   PubMed Web of Science ®Google Scholar
• . Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med. 2007;37(1):97–107
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV, Spencer T, . Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(12):1792–1798
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision). Arlington, VA: American Psychiatric Association; 2000
   Google Scholar
• . Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry. 1990;31(5):416–425
   PubMed Web of Science ®Google Scholar
• . Sobanski E, Brüggemann D, Alm B, . Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2007;257(7):371–377
   PubMed Web of Science ®Google Scholar
• . Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics. 2005;23(1):93–102
   PubMed Web of Science ®Google Scholar
• . Eyestone LL, Howell RJ. An epidemiological study of attention-deficit hyperactivity disorder and major depression in a male prison population. Bull Am Acad Psychiatry Law. 1994;22(2):181–193
   PubMedGoogle Scholar
• . Hinnenthal JA, Perwien AR, Sterling KL. A comparison of service use and costs among adults with ADHD and adults with other chronic diseases. Psychiatr Serv. 2005;56(12):1593–1599
   PubMed Web of Science ®Google Scholar
• . Fishman PA, Stang PE, Hogue SL. Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care. J Clin Psychiatry. 2007;68(2):248–253
   PubMed Web of Science ®Google Scholar
• . Sheehan DV, Lecrubier Y, Sheehan KH, . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59( suppl 20):22–33
   PubMed Web of Science ®Google Scholar
• . Winokur G, Coryell W, Endicott J, Akiskal H. Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am J Psychiatry. 1993;150(8):1176–1181
   PubMed Web of Science ®Google Scholar
• . Adler LA, Maya E, Sitt D, Dostal P. Issues in the treatment and diagnosis of ADHD by primary care physicians. Presented at: the American Psychiatric Association Annual Meeting; May 2006; Toronto, ON
   Google Scholar
• . Goodman D. Treatment and assessment of ADHD in adults. In: Biederman J, ed. ADHD Across the Lifespan: An Evidence-Based Understanding From Research to Clinical Practice. Hasbrouck Heights, NJ: Veritas Institute for Medical Education, Inc and MedLearning, Inc; 2006:227–270
   Google Scholar
• . Murphy KR, Adler LA. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry. 2004;65( suppl 3):12–17
   PubMed Web of Science ®Google Scholar
• . Montano B. Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry. 2004;65( suppl 3):18–21
   PubMed Web of Science ®Google Scholar
• . Adderall XR [package insert]. Wayne, PA: Shire US, Inc; 2008
   Google Scholar
• . Concerta [package insert]. Mountain View, CA: ALZA Corporation; 2008
   Google Scholar
• . Focalin XR [package insert]. East Hanover, NJ: Novartis Pharmaceutical Corp; 2008
   Google Scholar
• . Strattera [package insert]. Indianapolis, IN: Eli Lilly & Co; 2008
   Google Scholar
• . Vyvanse [package insert]. Wayne, PA: Shire US, Inc; 2008
   Google Scholar
• . Biederman J, Mick E, Surman C, . A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829–835
   PubMed Web of Science ®Google Scholar
• . Medori R, Ramos-Quiroga JA, Casas M, . A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008;63(10):981–989
   PubMed Web of Science ®Google Scholar
• . Chronis-Tuscano A, Seymour KE, Stein MA, . Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting. J Clin Psychiatry. 2008;69(12):1938–1947
   PubMed Web of Science ®Google Scholar
• . Adler LA, Zimmerman B, Starr HL, . Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol. 2009;29(3):239–247
   PubMed Web of Science ®Google Scholar
• . Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L; Adult ADHD Research Group. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007; 61(12):1380–1387
   PubMed Web of Science ®Google Scholar
• . Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Atten Disord. 2009;12(5):449–459
   PubMed Web of Science ®Google Scholar
• . Weisler RH, Biederman J, Spencer TJ, . Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11(8):625–639
   PubMed Web of Science ®Google Scholar
• . Adler LA, Spencer T, Brown TE, . Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol. 2009;29(1):44–50
   PubMed Web of Science ®Google Scholar
• . Adler LA, Goodman DW, Kollins SH, .; 303 Study Group. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008; 69(9):1364–1373
   PubMed Web of Science ®Google Scholar
• . Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L. Long-term safety and efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Poster presented at: US Psychiatric and Mental Health Congress; October 30–November 2, 2008; San Diego, CA
   Google Scholar
• . Brams M. Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder in the adult workplace environment. Paper presented at: Annual Meeting of the New Clinical Drug Evaluation Unit; June 29–July 2, 2009; Hollywood, FL
   Google Scholar
• . Wilens TE, McDermott SP, Biederman J, Abrantes A, Hahesy A, Spencer TJ. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J Cognitive Psychother. 1999;13(3):215–226
   Google Scholar
• . Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005;43(7):831–842
   PubMed Web of Science ®Google Scholar
• . Solanto MV, Marks DJ, Mitchell KJ, Wasserstein J, Kofman MD. Development of a new psychosocial treatment for adult ADHD. J Atten Disord. 2008;11(6):728–736
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Biederman J, Prince J, . Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153(9):1147–1153
   PubMed Web of Science ®Google Scholar
• . Hornig-Rohan M, Amsterdam JD. Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression. Prog Neuropsy-chopharmacol Biol Psychiatry. 2002;26(3):585–589
   PubMed Web of Science ®Google Scholar
• . Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol. 1996;6(3):165–175
   PubMed Web of Science ®Google Scholar
• . Weiss M, Hechtman L; Adult ADHD Research Group. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry. 2006; 67(4):611–619
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Prince JB, Spencer T, . An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry. 2003;54(1):9–16
   PubMed Web of Science ®Google Scholar